Clinical Trial Update: SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase II trial evaluating neoadjuvant atezolizumab with doxorubicin, concurrent atezolizumab with pre-operative radiation therapy, and adjuvant atezolizumab i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: RECRUITING